Pfizer, Inc. (PFE) Tops Q3 EPS by 2c; Boosts FY13 Outlook

October 29, 2013 7:02 AM

Pfizer, Inc. (NYSE: PFE) reported Q3 EPS of $0.58, $0.02 better than the analyst estimate of $0.56 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found